Thrombus Aspiration during STEMI: A Propensity Analysis in a Large Real World Cohort
|
STD [n=1450] |
TA [n=537] |
P-value |
|
Age (year) |
61±12 |
59±12 |
0.01 |
Male |
81% |
85% |
0.1 |
Ant MI |
45% |
45% |
0.99 |
Killip>1 |
14% |
12% |
0.6 |
DM |
27% |
23% |
0.06 |
Renal failure |
13% |
9.5% |
0.02 |
Cadillac score |
4.05±3.5 |
4.2±3.4 |
0.5 |
Final TIMI3 |
95% |
98% |
0.02 |
12 month Death |
5.5% |
3.8% |
0.1 |
12 month MI |
4.8% |
4.1% |
0.5 |
12 month Definite Stent thrombosis |
2.5% |
1.6% |
0.2 |
12 month TVR |
11.4% |
9.2% |
0.2 |
12 month MACE |
18.8% |
14.3% |
0.03 |
We used a non-conditional logistic regression model to determine independent significance of TA as a predictor of one year outcomes. Models were adjusted for the Cadillac score and the propensity score by introducing it as a covariate in each model. TA was not significant while Cadillac score was a significant predictor for one year MACE [OR1.17; 95% CI=1.17-1.2; P=0..001]
Conclusions: In this large cohort of real-world, TA did not reduce one year clinical outcomes among patients with STEMI